936330-65-3

Upstream product

• 195388-47-7 (S)-1,2-dihydro-1-hydroxy-7-methoxynaphthalene 
• 58479-61-1 tert-butylchlorodiphenylsilane 

Downstream Products

• 1313594-45-4 (S)-4-hydroxy-4-phenylnaphthalen-1(4H)-one 
• 1313594-44-3 (S)-4-phenyl-1,2-dihydronaphthalen-1-ol 
• 1313594-43-2 (S)-tert-butyldiphenyl(4-phenyl-1,2-dihydronaphthalen-1-yloxy)silane 
• 1313594-42-1 (S)-(4-bromo-1,2-dihydronaphthalen-1-yloxy)(tert-butyl)diphenylsilane 
• 885122-07-6 (1S,3S)-1-tert-butyldiphenylsiloxy-3-hydroxy-3-isopropenyl-1,2,3,4-tetrahydro-naphthalen-3-one 
• 885122-10-1 (S)-1-tert-butyldiphenylsiloxy-3-hydroxy-1,2,3,4-tetrahydro-naphthalen-3-one 
• 936330-66-4 (1S)-1-tert-butyldiphenylsiloxy-3-hydroxy-1,2,3,4-tetrahydro-naphthalene 
• 936330-68-6 (1S,3S)-1-tert-butyldiphenylsiloxy-3-acetyl-3-hydroxy-1,2,3,4-tetrahydro-naphthalene 

Relevant academic research and scientific papers

Synthesis and evaluation of (1S)-1,2-dihydro-1-naphthalenol derivatives against PANC-1 cells

Several derivatives of (1S)-1,2-dihydro-1-naphthalenol ((S)-7) have been synthesized and evaluated against human pancreatic adenocarcinoma cell line PANC-1 under nutrient-rich and nutrient-deprived conditions. The tert-butyldiphenylsilyl protected homoall

A catalytic asymmetric entry to enantioenriched tertiary naphthoquinols via a facile tandem oxidation/ring-opening sequence

The tertiary naphthoquinol is a key structural component of the antitumor natural products spiroxins A-E. Herein we report the first catalytic asymmetric approach to the tertiary naphthoquinol C4′ stereogenic center present in the spiroxin framework, via

Synthesis of daunorubicin analogues containing truncated aromatic cores and unnatural monosaccharide residues

(Chemical Equation Presented) The anthracycline antibiotics daunorubicin and doxorubicin have been used widely as anticancer drugs, but their cardiotoxicity limits their clinical use. We describe here the preparation of a small panel of daunorubicin analo